NASDAQ · ILMN
Illumina, Inc.
$236.49-$53.57 (-18.47%)
Illumina, Inc.’s quoted price sits in the upper half of its reported 52-week range, 23.35% below the high.
Loading market information…
SES · 8YY.SI · SGD
Stock price, earnings
Quote as of Oct 30, 2026, 08:59 AM UTC. Cached market data; not a live quote.
One-year closing-price history · SGD. Historical prices are not a forecast.
Embracing Future Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 73.91% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Embracing Future Holdings Limited’s next earnings report is currently expected on Feb 26, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Embracing Future Holdings Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Embracing Future Holdings Limited, a Singapore-based medical technology firm, specializes in precision medicine, focusing on developing diagnostic solutions. Operating across Japan, Hong Kong, Thailand, Malaysia, and the United States, its business is structured into Cancer, Infectious Diseases, and Laboratory Services segments. The company's key innovations include the ClearCell FX1 System, an automated device that, using Streck Cell-free DNA BCT and EDTA tubes, isolates intact and viable circulating tumor cells (CTCs) from small blood samples. It also provides the CTChip FR1 biochip for separating CTCs from leukocytes, alongside offering general laboratory services. Established in 2009, the company was formerly known as Biolidics Limited, adopting its current name in June 2025.
Latest available per-share figures in SGD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:04 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$236.49-$53.57 (-18.47%)
Illumina, Inc.’s quoted price sits in the upper half of its reported 52-week range, 23.35% below the high.
SGD 12.96+SGD 0.08 (+0.62%)
Haw Par Corporation Limited’s quoted price sits in the lower half of its reported 52-week range, 29.06% below the high.
SGD 0.82+SGD 0.01 (+0.61%)
Raffles Medical Group Ltd’s quoted price sits in the lower half of its reported 52-week range, 24.07% below the high.
SGD 0.74-SGD 0.01 (-0.68%)
Riverstone Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 25.38% below the high.
SGD 0.51+SGD 0.01 (+2.0%)
iX Biopharma Ltd.’s quoted price sits in the upper half of its reported 52-week range, 18.4% below the high.
SGD 0.34SGD 0.00 (0.0%)
HC Surgical Specialists Limited’s quoted price sits in the lower half of its reported 52-week range, 15.0% below the high.
SGD 0.09-SGD 0.00 (-1.09%)
Cordlife Group Limited’s quoted price sits in the lower half of its reported 52-week range, 65.0% below the high.
SGD 0.00SGD 0.00 (0.0%)
Clearbridge Health Limited’s quoted price sits in the lower half of its reported 52-week range, 66.67% below the high.
